Virtus Biotech ETF
26 hedge funds and large institutions have $27M invested in Virtus Biotech ETF in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
55% more capital invested
Capital invested by funds: $17.5M → $27M (+$9.53M)
30% more funds holding
Funds holding: 20 → 26 (+6)
14.49% more ownership
Funds ownership: 39.73% → 54.22% (+14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.29M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.44M |
| 3 |
WI
WBI Investments
Red Bank,
New Jersey
|
+$1.31M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$998K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$909K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCIA
Prime Capital Investment Advisors
Overland Park,
Kansas
|
-$566K |
| 2 |
CFP
Comprehensive Financial Planning
East Petersburg,
Pennsylvania
|
-$557K |
| 3 |
CAMG
CWA Asset Management Group
Naples,
Florida
|
-$204K |
| 4 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
-$104K |
| 5 |
HIA
Harbor Investment Advisory
Lutherville,
Maryland
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $83 | +$82 | +1 | New |
|
|
CFP
27
Comprehensive Financial Planning
East Petersburg,
Pennsylvania
| – | -$557K | -6,971 | Closed |
|
|
HIA
28
Harbor Investment Advisory
Lutherville,
Maryland
| – | -$22K | -275 | Closed |
|
BBP Hedge Fund Activity: Q1 2026 in Review
26 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2026, worth a combined $27M — up 55% from $17.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BBP positions and 2 closed out — a net gain of 7 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $2.29M. The largest seller was Prime Capital Investment Advisors, cutting an estimated $566K.
- 26 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2026, up from 20 in Q4 2025.
- Funds reported $27M of Virtus Biotech ETF stock for Q1 2026, up 55% quarter-over-quarter.
- 9 funds opened new Virtus Biotech ETF positions in Q1 2026 and 2 closed out, a net change of +7 holders.
- The largest Virtus Biotech ETF buyer in Q1 2026 was Susquehanna International Group, an estimated $2.29M added.
- The largest Virtus Biotech ETF seller in Q1 2026 was Prime Capital Investment Advisors, an estimated $566K sold.
Based on aggregated 13F filings for Q1 2026.